investor.ajg.com
Investor Relations - Company Profile - Arthur J. Gallagher & Co.
Skip to main content. Skip to main Navigation. Arthur J. Gallagher and Co. Arthur J. Gallagher, Inc. Commercial Insurance and Risk Management. Alternative Risk and Captives. Commercial Surety and Bonds. Private Client and Personal Insurance. Trade Credit and Political Risk. Benefits and HR Consulting. Human Resources and Compensation. Institutional Investment and Fiduciary Services. Multinational Benefits and Human Resources. Claims Management and Third-Party Administration. Energy, Oil and Gas. Primary ...
investor.alaskaair.com
Investors | Investors | Alaska Airlines
Skip to main content. Stock Quote and Chart. Annual Reports and Proxy. Annual Meeting and Proxy. Relax on a Beach. Board Room Airport Lounge. Earn and Use Miles. Buy and Share Miles. Profile and Tier Status. Stock quote and chart. Annual reports and proxy. Annual meeting and proxy. Alaska Receives DOJ Clearance. December 6, 2016. Alaska to acquire Virgin America. Alaska Acquires Virgin America Investor Deck. Alaska Air Group Reports December 2016 and Full-Year Operational Results. 160; 1.80.
investor.alderbio.com
Our Mission - Alder Biopharmaceuticals
Annual Reports and Proxies. Annual Reports and Proxies. Alder is a clinical-stage biopharmaceutical company that discovers, develops, and seeks to commercialize therapeutic antibodies with the potential to transform current treatment paradigms in meaningful ways. The work being done at Alder today will potentially help those who suffer from migraine, autoimmune diseases, and inflammatory diseases. 2015 Alder Biopharmaceuticals Inc. Annual Reports and Proxies.
investor.alere.com
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@investor.alere.com. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
investor.aleris.com
Aleris - InvestorRoom - Aleris Overview
Aleris is a global leader in the production and sale of aluminum rolled products. From its headquarters in Cleveland, Ohio, Aleris operates 13 production facilities throughout the United States, Europe, and Asia, providing products and services to customers in a variety of industries. Mar 19, 2018. Aleris Reports Fourth Quarter and Full Year 2017 Results. Mar 14, 2018. Aleris to Announce Fourth Quarter and Full Year 2017 Financial Results on March 19. Mar 5, 2018. Monday, March 19, 2018. 1 216 910 3229.
investor.aligntech.com
Align Technology, Inc. - Investors
Align Technology’s market opportunity and value proposition are strong and we are continuing to execute our strategies to increase adoption and utilization of our products and services worldwide. Stock Quote and Chart. View all ». Jan 30, 2018 at 4:30 PM ET. Fourth Quarter 2017 Financial Results Conference. View all ». Mar 6, 2018. Align Technology to Host Investor Day on May 23, 2018. Mar 5, 2018. Kevin J. Dallas Joins Align Technology Board of Directors. Feb 28, 2018. Feb 8, 2018. Feb 8, 2018.
investor.alimerasciences.com
Investor Relations | Alimera Sciences
Skip to main navigation. Diabetic Macular Edema (DME). Retinal Vein Occlusion (RVO). Age-Related Macular Degeneration (AMD). Alimera Sciences’ primary focus is on ILUVIEN. Fluocinolone acetonide intravitreal implant) 0.19 mg. ILUVIEN is an intravitreal implant of fluocinolone acetonide and is the first DME treatment to deliver 36 months of continuous, low-dose corticosteroid therapy with a single injection. Feb 28, 2018. Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results. 2018 A...
investor.alkermes.com
Alkermes PLC > Investor Relations > Corporate Overview
Message from the CEO. Q2 2015 Alkermes plc Earnings Conference Call. 160;at 8:30 am ET. 160; 0.54. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Alkermes plc Reports Second Quarter 2015 Financial Results. Alkermes to Host Conference Call to Discuss Second Quarter 2015 Financial Results. Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming American Society of Clinical Psychopharmacology Annual Meeting. Goldman Sachs and Co. Jefferies and Co., Inc. JPMorgan Securities, Inc. Can I p...
investor.allegion.com
Allegion Investor Relations | Find Our Investor Services | Allegion
Safety and Security Institute. SEC and Financial Reports. Stock Quote and Chart. Sign Up for Allegion Updates. With a global network of pioneering, market-leading brands, proven operational excellence and financial performance, we expect Allegion to unlock inherent value for shareholders. See where Allegion has been and where it's growing. Take a look at our latest news and browse past company announcements. SEC and Financial Reports. Find ALLE's current stock price and compare that with market trends.
investor.allete.com
Investors | ALLETE, Inc.
Skip to main navigation. Section 16 Insider Trades. ALLETE common stock trades on the New York Stock Exchange under the ticker symbol ALE, and has paid consecutive dividends since 1950. The company has been headquartered in Duluth, Minnesota since 1906. Mar 15, 2018. ALLETE Clean Energy to Build Montana Wind Energy Facility to Supply Electricity to NorthWestern Energy under Power Sale Agreement. Mar 1, 2018. ALLETE Clean Energy to Sell Phase II of Thunder Spirit Wind Farm to Montana-Dakota Utilities.
investor.alliancetrust.co.uk
www.alliancetrusts.com (JavaScript: Redirect)
SOCIAL ENGAGEMENT